Elen Tolstik

Dr. Elen Tolstik

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
ETElen Tolstik
Elen Tolstik
LOLiubov Osminkina
Liubov Osminkina
CMChristian Matthäus
Christian Matthäus
MBMarkus Burkhardt
Markus Burkhardt
KTKonstantine Eduardovich Tsurikov
Konstantine Eduardovich Tsurikov
Vladimir SivakovVladimir Sivakov
Vladimir Sivakov

Verified
Journal Article
Open access
PDF file
ETElen Tolstik
Elen Tolstik
LOLiubov Osminkina
Liubov Osminkina
DADenis Akimov
Denis Akimov
MGMaxim Bronislavovich Gongalsky
Maxim Bronislavovich Gongalsky
AKAndrey Kudryavtsev
Andrey Kudryavtsev
Juergen PoppJuergen Popp
Juergen Popp
New approaches for visualisation of silicon nanoparticles (SiNPs) in cancer cells are realised by means of the linear and nonlinear optics in vitro. Aqueous colloidal solutions of SiNPs with sizes of about 10–40 nm obtained by ultrasound grinding of silicon nanowires were introduced into breast cancer cells (MCF-7 cell line). Further, the time-varying nanoparticles enclosed in cell structures were visualised by high-resolution structured illumination microscopy (HR-SIM) and micro-Raman spectroscopy. Additionally, the nonlinear optical methods of two-photon excited fluorescence (TPEF) and coherent anti-Stokes Raman scattering (CARS) with infrared laser excitation were applied to study the localisation of SiNPs in cells. Advantages of the nonlinear methods, such as rapid imaging, which prevents cells from overheating and larger penetration depth compared to the single-photon excited HR-SIM, are discussed. The obtained results reveal new perspectives of the multimodal visualisation and precise detection of the uptake of biodegradable non-toxic SiNPs by cancer cells and they are discussed in view of future applications for the optical diagnostics of cancer tumours.

22 November 2013 in Journal of the Optical Society of America B
Verified
Journal Article
Closed access
PDF file
YQYue Qi
Yue Qi
HLHaoyu Li
Haoyu Li
ETElen Tolstik
Elen Tolstik
JGJinxin Guo
Jinxin Guo
MGMichael R. Gleeson
Michael R. Gleeson
John SheridanJohn Sheridan
John Sheridan
Phenanthrenequinone (PQ) doped poly(methyl methacrylate) (PMMA) photopolymer material has received much attention in the literature. However, further development requires that a more physical material model be developed. In this article, such a model is presented. The model includes: (1) the time-varying photon absorption, including the absorptivity of a second absorber, i.e., the singlet excited state of PQ; (2) the recovery/regeneration and the bleaching of the excited-state PQ; (3) the nonlocal effect; and (4) the diffusion effects of both the ground- and excited-state PQ molecules and of the methyl methacrylate (MMA). A set of rate equations are derived, governing the temporal and spatial variations of each chemical component concentration. Compared to previous models presented in the literature in this paper: (1) the second absorber is included; (2) the diffusion of all the PQ states is considered; and (3) the first-harmonic refractive index modulation is calculated in a more physically reasonable way. Simulations of the normalized transmission are presented. The effects of the nonlocal material response and the diffusion of both ground-state and excited-state PQ molecules are also examined. The model is applied to analyze experimental results in Part 2 of this paper.

23 September 2019 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
PMPolina V. Maximchik
Polina V. Maximchik
KTKonstantin Tamarov
Konstantin Tamarov
ESEugene V. Sheval
Eugene V. Sheval
ETElen Tolstik
Elen Tolstik
TKTatiana Kirchberger-Tolstik
Tatiana Kirchberger-Tolstik
LOLiubov Osminkina
Liubov Osminkina

30 July 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
HKHelena Kerp
Helena Kerp
GHGeorg Sebastian Hönes
Georg Sebastian Hönes
ETElen Tolstik
Elen Tolstik
JHJudith Hönes-Wendland
Judith Hönes-Wendland
JGJanina Gassen
Janina Gassen
DFDagmar Führer-Sakel
Dagmar Führer-Sakel
Purpose: Thyroid hormones (TH) play a central role for cardiac function. TH influence heart rate and cardiac contractility, and altered thyroid function is associated with increased cardiovascular morbidity and mortality. The precise role of TH in onset and progression of heart failure still requires clarification.Methods: Chronic left ventricular pressure overload was induced in mouse hearts by transverse aortic constriction (TAC). One week after TAC, alteration of TH status was induced and the impact on cardiac disease progression was studied longitudinally over 4 weeks in mice with hypo- or hyperthyroidism and was compared to euthyroid TAC controls. Serial assessment was performed for heart function (2D M-mode echocardiography), heart morphology (weight, fibrosis, and cardiomyocyte cross-sectional area), and molecular changes in heart tissues (TH target gene expression, apoptosis, and mTOR activation) at 2 and 4 weeks.Results: In diseased heart, subsequent TH restriction stopped progression of maladaptive cardiac hypertrophy and improved cardiac function. In contrast and compared to euthyroid TAC controls, increased TH availability after TAC propelled maladaptive cardiac growth and development of heart failure. This was accompanied by a rise in cardiomyocyte apoptosis and mTOR pathway activation.Conclusion: This study shows, for the first time, a protective effect of TH deprivation against progression of pathological cardiac hypertrophy and development of congestive heart failure in mice with left ventricular pressure overload. Whether this also applies to the human situation needs to be determined in clinical studies and would infer a critical re-thinking of management of TH status in patients with hypertensive heart disease.

Verified
Journal Article
Open access
PDF file
ETElen Tolstik
Elen Tolstik
NANairveen Ali
Nairveen Ali
SGShuxia Guo
Shuxia Guo
PEPaul Ebersbach
Paul Ebersbach
DMDorothe Möllmann
Dorothe Möllmann
KLKristina Lorenz
Kristina Lorenz
Vibrational spectroscopy can detect characteristic biomolecular signatures and thus has the potential to support diagnostics. Fabry disease (FD) is a lipid disorder disease that leads to accumulations of globotriaosylceramide in different organs, including the heart, which is particularly critical for the patient’s prognosis. Effective treatment options are available if initiated at early disease stages, but many patients are late- or under-diagnosed. Since Coherent anti-Stokes Raman (CARS) imaging has a high sensitivity for lipid/protein shifts, we applied CARS as a diagnostic tool to assess cardiac FD manifestation in an FD mouse model. CARS measurements combined with multivariate data analysis, including image preprocessing followed by image clustering and data-driven modeling, allowed for differentiation between FD and control groups. Indeed, CARS identified shifts of lipid/protein content between the two groups in cardiac tissue visually and by subsequent automated bioinformatic discrimination with a mean sensitivity of 90–96%. Of note, this genotype differentiation was successful at a very early time point during disease development when only kidneys are visibly affected by globotriaosylceramide depositions. Altogether, the sensitivity of CARS combined with multivariate analysis allows reliable diagnostic support of early FD organ manifestation and may thus improve diagnosis, prognosis, and possibly therapeutic monitoring of FD.